Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 87 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 7763586

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 27, 2010 · Expires Jul 22, 2030

    granted

  2. US 7758855

    DNA promoters and anthrax vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted

  3. US 7759330

    21-substituted progesterone derivatives as new antiprogestational agents

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted

  4. US 7758876

    Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligonucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted

  5. US 7759106

    Construction of live attenuated Shigella vaccine strains that express CFA/I antigens (CfaB and CfaE) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic E. coli

    The United States of America as represented by the Secretary of the Army · Granted Jul 20, 2010 · Expires Jul 15, 2030

    granted

  6. US 7754227

    Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 13, 2010 · Expires Jul 8, 2030

    granted

  7. US 7754461

    Large-scale production of human serum butyrylcholinesterase as a bioscavenger

    The United States of America as represented by the Secretary of the Army · Granted Jul 13, 2010 · Expires Jul 8, 2030

    granted

  8. US 7754676

    Defensin-antigen fusion proteins

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 13, 2010 · Expires Jul 8, 2030

    granted

  9. US 7754420

    Methods of using cyanovirins to inhibit viral infection

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 13, 2010 · Expires Jul 8, 2030

    granted

  10. US 7749719

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 6, 2010 · Expires Jul 1, 2030

    granted

  11. US 7749967

    Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 6, 2010 · Expires Jul 1, 2030

    granted

  12. US 7749984

    Computer-based model for identification and characterization of non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 6, 2010 · Expires Jul 1, 2030

    granted

  13. US 7745212

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted

  14. US 7745144

    Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted

  15. US 7744902

    Respiratory syncytial virus vaccines expressing protective antigens from promotor-proximal genes

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted

  16. US 7745388

    Peptides for activation and inhibition of δPKC

    The United States of America as represented by NIH Division of Extramural Inventions and Technology Resources (DEITR) · Granted Jun 29, 2010 · Expires Jun 24, 2030

    granted

  17. US 7741437

    P. ariasi polypeptides, p. perniciosus polypeptides and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 22, 2010 · Expires Jun 17, 2030

    granted

  18. US 7740889

    Bacteriocins and novel bacterial strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Jun 22, 2010 · Expires Jun 17, 2030

    granted

  19. US 7741431

    Liposomes containing novel targeting and/or fusogenic peptides, preparations containing them and therapeutic use thereof

    The United States of America as represented by the Secretary of the Army · Granted Jun 22, 2010 · Expires Jun 17, 2030

    granted

  20. US 7741063

    Toxoplasma gondii oocyst protein

    The United States of America, as represented by the Secretary of Agriculture · Granted Jun 22, 2010 · Expires Jun 17, 2030

    granted

  21. US 7736656

    Immunogenic compositions and vaccines for Ebola

    The United States of America as represented by the Secretary of the Army · Granted Jun 15, 2010 · Expires Jun 10, 2030

    granted

  22. US 7731953

    Methods for use of TSLP and agonists and antagonists thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 8, 2010 · Expires Jun 3, 2030

    granted

  23. US 7731971

    Enhanced CTL epitope-containing HIV-1 reverse transcriptase polypeptides

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 8, 2010 · Expires Jun 3, 2030

    granted

  24. US 7731975

    Chimeric filovirus glycoprotein

    The United States of America as represented by the Secretary of the Army · Granted Jun 8, 2010 · Expires Jun 3, 2030

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.